Amarin (AMRN) News Today $15.58 -0.40 (-2.50%) As of 02:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMRN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025August 25 at 8:00 AM | globenewswire.comAmarin (NASDAQ:AMRN) Share Price Passes Above 200 Day Moving Average - What's Next?August 23 at 4:26 AM | marketbeat.comAmarin (NASDAQ:AMRN) Stock Price Crosses Above 200 Day Moving Average - Here's What HappenedAugust 14, 2025 | marketbeat.comLCM Capital Management Inc Has $385,000 Position in Amarin Corporation PLC (NASDAQ:AMRN)August 6, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Stock Rating Upgraded by Wall Street ZenAugust 3, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Issues Quarterly Earnings ResultsAugust 2, 2025 | marketbeat.comZacks Research Analysts Cut Earnings Estimates for AmarinAugust 1, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Stock Price Crosses Above 200 Day Moving Average - What's Next?July 31, 2025 | marketbeat.comAmarin Corporation plc (AMRN) Q2 2025 Earnings Call TranscriptJuly 30, 2025 | seekingalpha.comAmarin Reports Second Quarter 2025 Financial ResultsJuly 30, 2025 | globenewswire.comAmarin Q2 2025 Earnings PreviewJuly 29, 2025 | msn.comAMRN - Amarin Corp PLC ADR Key Metrics - MorningstarJuly 25, 2025 | morningstar.comMAmarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025July 23, 2025 | globenewswire.comAmarin (AMRN) Expected to Announce Quarterly Earnings on WednesdayJuly 23, 2025 | marketbeat.comAmarin Corporation PLC (NASDAQ:AMRN) Stock Holdings Lowered by OneDigital Investment Advisors LLCJuly 12, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Share Price Crosses Above 200-Day Moving Average - What's Next?July 8, 2025 | marketbeat.comWaterfront Wealth Inc. Has $1.13 Million Stock Holdings in Amarin Corporation PLC (NASDAQ:AMRN)June 29, 2025 | marketbeat.comWhat is Zacks Research's Estimate for Amarin Q3 Earnings?June 29, 2025 | marketbeat.comAmarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock? - NasdaqJune 27, 2025 | nasdaq.comAmarin (NASDAQ:AMRN) Given New $12.00 Price Target at The Goldman Sachs GroupJune 25, 2025 | marketbeat.comAmarin, Recordati Ink Exclusive License, Supply Deal to Commercialize VazkepaJune 24, 2025 | marketwatch.comAmarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in EuropeJune 24, 2025 | finance.yahoo.comAmarin Stock Surges 11% After $25 Million Licensing Deal with RecordatiJune 24, 2025 | msn.comAmarin inks licensing deal with Recordati for lead drug VazkepaJune 24, 2025 | msn.comRECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPEJune 24, 2025 | globenewswire.comAmarin (NASDAQ:AMRN) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?June 24, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Stock Passes Above Two Hundred Day Moving Average - Here's What HappenedJune 14, 2025 | marketbeat.comAmarin Is A Sell Despite The Large Cash BalanceJune 6, 2025 | seekingalpha.comZacks Research Has Positive Estimate for Amarin Q2 EarningsJune 6, 2025 | marketbeat.comShort Interest in Amarin Co. plc (NASDAQ:AMRN) Grows By 18.3%June 4, 2025 | marketbeat.comAMRN Amarin Corporation plcJune 1, 2025 | seekingalpha.comZacks Research Issues Positive Estimate for Amarin EarningsMay 31, 2025 | marketbeat.comWhat’s Trending On InvestorshubMay 27, 2025 | msn.comAmarin (NASDAQ:AMRN) Stock Price Passes Above 200 Day Moving Average - What's Next?May 26, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?May 18, 2025 | marketbeat.comEarnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Boosting Their EstimatesMay 10, 2025 | finance.yahoo.comAmarin (NASDAQ:AMRN) Shares Cross Above 200 Day Moving Average - Should You Sell?May 10, 2025 | marketbeat.comAmarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ...May 8, 2025 | finance.yahoo.comAmarin Reports First Quarter 2025 Financial ResultsMay 7, 2025 | finance.yahoo.comAmarin Q1 2025 Earnings PreviewMay 6, 2025 | msn.com7AMRN : Exploring Amarin Corp's Earnings ExpectationsMay 6, 2025 | benzinga.comAmarin (AMRN) Expected to Announce Earnings on WednesdayMay 2, 2025 | marketbeat.comAmarin Corporation plc: Amarin Regains Compliance with Nasdaq Minimum Bid Price RequirementApril 30, 2025 | finanznachrichten.deAmarin Corporation plc to Host Conference Call for First Quarter 2025 Financial ResultsApril 30, 2025 | nasdaq.comAmarin Regains Compliance with Nasdaq Minimum Bid Price RequirementApril 29, 2025 | globenewswire.comResearch Analysts Set Expectations for Amarin Q1 EarningsApril 29, 2025 | marketbeat.comAmarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025April 28, 2025 | globenewswire.comQ1 Earnings Forecast for Amarin Issued By Zacks ResearchApril 27, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Stock Crosses Above 200-Day Moving Average - Here's What HappenedApril 27, 2025 | marketbeat.comTop 2 Health Care Stocks That May Crash This MonthApril 25, 2025 | benzinga.com Get Amarin News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address AMRN Media Mentions By Week AMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRN News Sentiment▼1.280.71▲Average Medical News Sentiment AMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRN Articles This Week▼22▲AMRN Articles Average Week Get Amarin News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Avadel Pharmaceuticals News Evotec News Phibro Animal Health News Tilray Brands News CureVac News Collegium Pharmaceutical News Calliditas Therapeutics AB (publ) News Xeris Biopharma News Enliven Therapeutics News Pharvaris News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRN) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amarin Corporation PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Amarin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access